Dopamine And Norepinephrine Reuptake Inhibitors

DBCAT005675Therapeutic category

Drugs that block specific transporter proteins, increasing the amount of active norepinephrine and dopamine neurotransmitters in the brain. A DrugBank category of 2 drugs. 2 of them are approved.

Drugs: Bupropion
Solriamfetol

What you can answer from here — as of October 05, 2023

2DrugsEach linked to its full drug card

Listed above

5Drug targetsEvery drug–target pair in the class, with bond type

1,162Marketed productsAcross the regions we cover, with dosage forms and routes

2Routes of administrationHow the drugs in this class are given

Which targets do Dopamine And Norepinephrine Reuptake Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account